![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
June 15, 2006
SSRIs,
Suicide, and Other Treatment (DrugWonks.com)
The risk of suicide related
to selective serotonin reuptake inhibitors (SSRIs) has recently developed into
a heated and emotion-fraught issue. In his entry, blogger Peter Pitts discusses
SSRIs studies, suicide rates, and the various treatments available to people with
clinical depression.
The
Ketek Crisis Continues (Eye On FDA)
Citing a recent ABC News report
about sanofi-aventis' embattled antibiotic Ketek, blogger Mark Senak discusses
Sen. Chuck Grassley's criticism of the FDA about the issue, and lambastes the
agency's "continued inability to respond with a communications strategy in
the face of a crisis and the intrinsic link between the image of the agency and
the image of the pharmaceutical industry itself."
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct